Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |